MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy

Myotonic dystrophy involves two types of chronically debilitating rare neuromuscular diseases: type 1 (DM1) and type 2 (DM2). Both share similarities in molecular cause, clinical signs, and symptoms with DM2 patients usually displaying milder phenotypes. It is well documented that key clinical sympt...

Descripción completa

Detalles Bibliográficos
Autores principales: López Castel, Arturo, Overby, Sarah Joann, Artero, Rubén
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888406/
https://www.ncbi.nlm.nih.gov/pubmed/31717488
http://dx.doi.org/10.3390/ijms20225600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888406/
https://www.ncbi.nlm.nih.gov/pubmed/31717488
http://dx.doi.org/10.3390/ijms20225600

Ejemplares similares